- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics of ketamine: A systematic review
Authors
Keywords
Ketamine, Esketamine, Pharmacogenetic, CYP450, CYP2B6, BDNF, Depression, Suicide, Bipolar disorder, Predicters
Journal
JOURNAL OF PSYCHIATRIC RESEARCH
Volume 145, Issue -, Pages 27-34
Publisher
Elsevier BV
Online
2021-11-24
DOI
10.1016/j.jpsychires.2021.11.036
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials
- (2020) Ziad Saad et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial
- (2020) Michael F. Grunebaum et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Ketamine Pharmacokinetics
- (2020) Jasper Kamp et al. ANESTHESIOLOGY
- Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
- (2020) Anees Bahji et al. JOURNAL OF AFFECTIVE DISORDERS
- Pharmacogenetics in Psychiatry: An Update on Clinical Usability
- (2020) Ron H. N. van Schaik et al. Frontiers in Pharmacology
- Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study
- (2020) Mu-Hong Chen et al. GENOMICS
- The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
- (2020) Jiaqi Xiong et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)
- (2019) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
- (2018) Carola Rong et al. International Journal of Environmental Research and Public Health
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis
- (2018) Joshua D. Rosenblat et al. JOURNAL OF AFFECTIVE DISORDERS
- Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials
- (2018) Chad A Bousman et al. PHARMACOGENOMICS
- Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
- (2018) Wei Guo et al. Translational Psychiatry
- Factors Influencing the Cardiovascular Response to Subanesthetic Ketamine: A Randomized, Placebo-Controlled Trial
- (2017) Thomas Liebe et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder?
- (2017) Joshua D. Rosenblat et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacogenetics of Ketamine-Induced Emergence Phenomena
- (2017) Edwin N. Aroke et al. NURSING RESEARCH
- CYP2B6*6allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects
- (2015) Yibai Li et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Erratum: Sex differences in glutamate receptor gene expression in major depression and suicide
- (2015) A L Gray et al. MOLECULAR PSYCHIATRY
- A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression
- (2013) Chen Zhang et al. PSYCHOPHARMACOLOGY
- Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
- (2013) Ulrich M. Zanger et al. Frontiers in Genetics
- Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
- (2012) Gonzalo Laje et al. BIOLOGICAL PSYCHIATRY
- Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Investigation of the correlation between norepinephrine transporter gene polymorphisms and essential hypertension
- (2012) YING LI et al. Molecular Medicine Reports
- A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action
- (2012) Kenji Hashimoto Clinical Psychopharmacology and Neuroscience
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Effects ofBDNFPolymorphisms on Antidepressant Action
- (2011) Shih-Jen Tsai et al. Psychiatry Investigation
- Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
- (2010) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started